Arteriovenous Malformations (AVMs) stand out as the largest single application segment driving the consumption of liquid embolic agents, currently accounting for a substantial portion of the domain's total revenue. AVMs are abnormal tangles of blood vessels that bypass the normal capillary system, and when they occur in the brain, they carry a high risk of rupture and catastrophic hemorrhage....